Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-806,170
Closed -$30.8M 55
2016
Q4
$30.8M Sell
806,170
-611,460
-43% -$22.7M 1.73% 29
2016
Q3
$54M Sell
1,417,630
-170,305
-11% -$7.57M 3.05% 18
2016
Q2
$68.7M Buy
1,587,935
+27,060
+2% +$1.2M 3.36% 11
2016
Q1
$72.3M Buy
1,560,875
+320,460
+26% +$15.5M 3.88% 9
2015
Q4
$67.1M Sell
1,240,415
-396,375
-24% -$19.1M 3.67% 10
2015
Q3
$65.9M Buy
1,636,790
+935,955
+134% +$52.2M 3.63% 11
2015
Q2
$47.6M Sell
700,835
-332,820
-32% -$23.5M 2.37% 20
2015
Q1
$61.3M Sell
1,033,655
-75,975
-7% -$4.33M 3.12% 16
2014
Q4
$62.5M Sell
1,109,630
-529,494
-32% -$28.4M 3.86% 10
2014
Q3
$74.6M Buy
1,639,124
+547,400
+50% +$26.6M 4.33% 3
2014
Q2
$56.3M Buy
1,091,724
+26,415
+2% +$1.3M 3.34% 16
2014
Q1
$52M Sell
1,065,309
-8,575
-0.8% -$416K 3.35% 13
2013
Q4
$46.6M Sell
1,073,884
-504,750
-32% -$20.7M 3.31% 16
2013
Q3
$60.3M Sell
1,578,634
-38,350
-2% -$1.35M 4.75% 3
2013
Q2
$50.2M Buy
+1,616,984
New +$48.3M 4.12% 2

Other funds holding VTRS

M.D. Sass LLC's VTRS Position: Q1 2017 in Review

M.D. Sass LLC sold out of Viatris (VTRS) in Q1 2017, closing a stake of 806,170 shares — an estimated $30.8M sold.

M.D. Sass LLC first reported a position in VTRS in Q2 2013 and held it in 15 quarters. The position peaked at $74.6M in Q3 2014. 568 funds tracked by Wall St. Rank hold VTRS as of Q1 2017.

  • M.D. Sass LLC reported no remaining Viatris position as of Q1 2017 after selling out during the quarter.
  • M.D. Sass LLC sold 806,170 Viatris shares in Q1 2017, an estimated $30.8M.
  • M.D. Sass LLC first reported a position in Viatris in Q2 2013 and held it in 15 quarters.
  • M.D. Sass LLC's Viatris position peaked at $74.6M in Q3 2014.
  • 568 funds tracked by Wall St. Rank held Viatris as of Q1 2017.

Based on M.D. Sass LLC's 13F filing for Q1 2017, filed 12 May 2017.